Daidzein

Alternative names

(R)-limonene 6-monooxygenase, (S)-limonene 6-monooxygenase, (S)-limonene 7-monooxygenase, ACLS, AHR_HUMAN, AIS, ANDR_HUMAN, AR, AR8, Ah receptor, Amine oxidase (flavin containing), Amine oxidase (flavin containing) A, Amine oxidase (flavin containing) B, Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease), Antigen NY-CO-13, Aromatic hydrocarbon receptor, Aryl hydrocarbon receptor, Aryl hydrocarbon receptor precursor, Atherosclerosis, susceptibility to, included, BCC7, BCD541, BXR, CA 12, CA 7, CA IV, CA-VII, CA-XII, CA4, CAC1C_HUMAN, CACH 2, CACN 2, CACNL1A1, CAH12_HUMAN, CAH4_HUMAN, CAH7_HUMAN, CAR, CAR BETA, CARA, CCHL1A1, CP2C9_HUMAN, CPC12, CPC8, CPC9, CPCJ, CYP2C, CYP2C10, CYPIIC9, CaV1.2, Calcium channel, Calcium channel L type alpha 1 polypeptide isoform 1 cardiac muscle, Calcium channel cardic dihydropyridine sensitive alpha 1 subunit, Calcium channel voltage dependent L type alpha 1C subunit, Car 1, Car4, Carbonate dehydratase IV, Carbonate dehydratase VII, Carbonate dehydratase XII, Carbonic anhydrase 12, Carbonic anhydrase 4, Carbonic anhydrase 7, Carbonic anhydrase VII, Carbonic anhydrase XII, Carbonic dehydratase, Carbonic dehydratase IV, Carbonic dehydratase VII, Cellular tumor antigen p53, Class E basic helix-loop-helix protein 76, Component of gems 1, Constitutive activator of retinoid response, Constitutive active response, Constitutive androstane receptor, Cytochrome P-450MP, Cytochrome P450 2C9, Cytochrome P450 MP-4, Cytochrome P450 MP-8, Cytochrome P450 PB-1, Cytochrome P450, family 2, subfamily C, polypeptide 9, DHPR alpha 1, DHPR alpha 1 subunit, DHTR, DKFZp686N23123, DNA binding protein, Dihydro testosterone receptor, Dihydrotestosterone receptor (DHTR), EC 4.2.1.1, EC=4.2.1.1, ER, ER-alpha, ER-beta, ERR a, ERR-alpha, ERR1 protein, ERR1_HUMAN, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR1_HUMAN, ESRA, ESRL 1, ESRR A, ESTR B, Era, Erb, Erb2, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta 4, Estrogen receptor related 1, Estrogen receptor-like 1, Estrogen resistance, included, Estrogen-related receptor alpha, Estrra, FLJ20151, FLJ92943, GCCR, GCPS, GCRST, GCR_HUMAN, GLI Kruppel family member GLI 3, GLI Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome), GLI family zinc finger 3, GLI3 C-terminally truncated form, GLI3 form of 190 kDa, GLI3 form of 83 kDa, GLI3 full length protein, GLI3-190, GLI3-83, GLI3FL, GLI3_HUMAN, GR, Gemin-1, Glioma associated oncogene family zinc finger 3, Glucocorticoid receptor, Grl1, HD 7, HD 7B, HD 9, HDAC, HDAC 7B, HDAC 9B, HDAC 9FL, HDAC9_HUMAN, HDL cholesterol, augmented response of, to hormone replacement, included, HDRP, HGNC:348, HUMARA, HYSP1, Histone deacetylase 4/5 related protein, Histone deacetylase 7, Histone deacetylase 7B, Histone deacetylase 9, Histone deacetylase 9A, Histone deacetylase-related protein, HsT18816, KD, KIAA0744, Kennedy disease (KD), L type, LFS1, LQT8, MAO, MAO-A, MAO-B, MB67, MEF2 interacting transcription repressor protein, MEF2-interacting transcription repressor MITR, MGC149605, MGC88320, MGC97144, MITR, Microsomal monooxygenase, Monoamine oxidase, Monoamine oxidase A, Monoamine oxidase B, Monoamine oxidase type A, Monoamine oxidase type B, Mutant tumor protein 53, Myocardial infarction, susceptibility to, included, NR1B1, NR1I2_HUMAN, NR1I3_HUMAN, NR3A1, NR3A2, NR3B1, NR3C4, Nuclear mitotic apparatus protein retinoic acid receptor alpha fusion protein, Nuclear receptor subfamily 1 group B member 1, Nuclear receptor subfamily 1 group I member 2, Nuclear receptor subfamily 1 group I member 3, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, Nuclear receptor subfamily 3 group B member 1, Nuclear receptor subfamily 3 group C member 1, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), Nucleophosmin retinoic acid receptor alpha fusion protein NPM RAR long form, ONR 1, OTTHUMP00000017718, OTTHUMP00000017719, OTTHUMP00000020135, OTTHUMP00000125198, OTTHUMP00000215173, OTTHUMP00000215174, OTTHUMP00000215175, OTTHUMP00000223567, OTTHUMP00000223568, OTTHUMP00000224066, OTTHUMP00000226924, Oncogene GLI3, Orphan nuclear receptor MB67, Orphan nuclear receptor NR1I3, Orphan nuclear receptor PAR 1, Orphan nuclear receptor PXR, P450 MP, P450 PB 1, P450C2C, P450IIC19, P450IIC9, P53_HUMAN, PAP A, PAPB, PAR, PAR q, PPD IV, PRR, Phosphoprotein p53, Pregnane X receptor, RAR, RAR-alpha, RARA_HUMAN, RARalpha1, RNESTROR, RP17, Retinitis pigmentosa 17 (autosomal dominant), Retinoic acid nuclear receptor alpha variant 1, Retinoic acid nuclear receptor alpha variant 2, Retinoic acid receptor alpha, Retinoic acid receptor alpha polypeptide, S-mephenytoin 4-hydroxylase, SBMA, SMA, SMA 1, SMA 2, SMA 3, SMA 4, SMAX1, SMN1, SMN2, SMNT, SMN_HUMAN, SXR, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), Steroid and xenobiotic receptor, Steroid hormone receptor ERR1, Survival motor neuron protein, Survival of motor neuron 1, telomeric, T-BCD541, T18816, TFM, TRP53, TS, Testicular Feminization (TFM), Tp53, Transcriptional activator GLI3, Transcriptional repressor GLI3R, Transformation related protein 53, Tumor antigen HOM-RCC-3.1.3, Tumor protein 53, Tumor protein p53, Tumor suppressor p53, Voltage dependent L type calcium channel alpha 1C subunit, Voltage gated L type calcium channel Cav1.2 alpha 1 subunit, splice variant 10*, Voltage gated calcium channel alpha subunit Cav1.2, Voltage-dependent L-type calcium channel subunit alpha-1C, Voltage-gated calcium channel subunit alpha Cav1.2, Xenobiotic monooxygenase, Zinc finger protein GLI 3, alpha-1 polypeptide, androgen receptor splice variant 4b, bHLHe76, cardiac muscle, constitutive active receptor, constitutive androstane nuclear receptor variant 2, constitutive androstane nuclear receptor variant 3, constitutive androstane nuclear receptor variant 4, constitutive androstane nuclear receptor variant 5, cytochrome P-450 S-mephenytoin 4-hydroxylase, estrogen receptor related receptor alpha, flavoprotein-linked monooxygenase, glucocorticoid nuclear receptor variant 1, hERR1, isoform 1, nr3c1, nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor), orphan nuclear hormone receptor, p53 tumor suppressor, pregnane X nuclear receptor variant 2, tumor antigen p55